Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06580782

Calcium Carbonate to Augment Labor Contractions

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Weill Medical College of Cornell University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.

Detailed description

This study plans to study the acceptance and safety of using calcium carbonate as an medicine to help the labor induction process. The study aims to find if the use of calcium carbonate will lead to better labor contractions and increase the percentage of vaginal deliveries and improve delivery outcomes.

Conditions

Interventions

TypeNameDescription
DRUGCalcium Carbonate 500 MGCalcium Carbonate 500mg, orally, every 4 hours.
DRUGStandard Dose Synthetic PitocinThe participant will receive thestandard-dose synthetic oxytocin for labor induction or augmentation.

Timeline

Start date
2024-11-18
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-08-30
Last updated
2025-10-23

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06580782. Inclusion in this directory is not an endorsement.